03.05.25
Nonwovenn is investing an additional £5 million of self-funded capex to support the next phase of expansion and developmen in its business. The latest investment follows the completion of the first phase of the business’ transformation program, where £13 million was invested into a new ‘operational excellence model’ including new manufacturing equipment, an end-to-end operational efficiency program and an enhancement in research and development and innovation capability.
The second phase of investment will focus on capacity increases and improved capability, and the company will spend the rest of 2025 and 2026 focus on chemical bonding production, increasinh volume through conversion of existing lines and the purchase of a new line. The enhanced capability is to support ambitious growth targets in the $5.5 billion global oral pouch delivery sector.
Investments in operational management capability have already begun, with a new operations director and operations manager appointed to the business and doubling the number of shift managers. The senior team is working with planning, health and safety and quality teams to ensure the current and new staff are fully supported with training and development opportunities. There has also been a 50 person increase in manufacturing recruitment, which combined with the launch of a new multi skilling prograe is designed to underpin the growth ambition.
“We have seen substantial growth and transformation from the first phase of investment. The additional £5 million reaffirms our commitment to driving innovation, efficiency and sustainability at Nonwovenn," says chairman David Lamb. “The shift to focus more on chemical bonding in 2025-26 marks a significant milestone, boosting our current capacity and a further 25% added when the new line is complete. The business is truly evolving, and we’re incredibly excited about what the future holds.”
Operations Director, Neil Thorn adds; “We have had significant operational and performance improvements through the investment made in phase one of our programme. It is very exciting to see the the Operational Excellence journey gaining momentum through investment in equipment and new management talent. This additional funding will allow us to bring people and operational excellence to the forefront of the business to support the levels of growth we are aiming for.”
Related Content:
— Nonwovenn Focuses on Oral Pouch Delivery Market
— Silke Brank-Kirsch Joins Nonwovenn
The second phase of investment will focus on capacity increases and improved capability, and the company will spend the rest of 2025 and 2026 focus on chemical bonding production, increasinh volume through conversion of existing lines and the purchase of a new line. The enhanced capability is to support ambitious growth targets in the $5.5 billion global oral pouch delivery sector.
Investments in operational management capability have already begun, with a new operations director and operations manager appointed to the business and doubling the number of shift managers. The senior team is working with planning, health and safety and quality teams to ensure the current and new staff are fully supported with training and development opportunities. There has also been a 50 person increase in manufacturing recruitment, which combined with the launch of a new multi skilling prograe is designed to underpin the growth ambition.
“We have seen substantial growth and transformation from the first phase of investment. The additional £5 million reaffirms our commitment to driving innovation, efficiency and sustainability at Nonwovenn," says chairman David Lamb. “The shift to focus more on chemical bonding in 2025-26 marks a significant milestone, boosting our current capacity and a further 25% added when the new line is complete. The business is truly evolving, and we’re incredibly excited about what the future holds.”
Operations Director, Neil Thorn adds; “We have had significant operational and performance improvements through the investment made in phase one of our programme. It is very exciting to see the the Operational Excellence journey gaining momentum through investment in equipment and new management talent. This additional funding will allow us to bring people and operational excellence to the forefront of the business to support the levels of growth we are aiming for.”
Related Content:
— Nonwovenn Focuses on Oral Pouch Delivery Market
— Silke Brank-Kirsch Joins Nonwovenn
